Regeneron Pharmaceuticals reported $20.07 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 20.07 13.04 11.83 Oct/30
FY2026Q2 Jun/2026 14.29 10.85 12.89 Jul/30
FY2026Q1 Mar/2026 9.47 9.13 8.22 Apr/29
FY2025Q4 Dec/2025 11.44 10.61 12.07 Jan/30
FY2025Q3 Sep/2025 11.83 9.67 12.46 Oct/28




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Agenus USD 1.02 1.32 Mar/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Astellas Pharma JPY 55.69 23.46 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Kyowa Hakko Kirin JPY 40.22 4.73 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 0.14 2.02 Jun/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026